Showing results (1941-1950 of 2,214) with videos related to

Sort By:
Pageof 222
Pediatric Obesity|August 16, 2022
Change in parent and child psychopathology following obesity treatment and maintenance: A secondary data analysisAnne Claire Grammer, John R Best, Lauren A Fowler, et al.
Journal of Veterinary Internal Medicine|April 8, 2020
Extracellular vesicular microRNAs as potential biomarker for early detection of doxorubicin-induced cardiotoxicityAmelie Beaumier, Sally R Robinson, Nicholas Robinson, et al.
Female Pelvic Medicine & Reconstructive Surgery|May 7, 2020
It Takes a Village: The First 100 Patients Seen in a Multidisciplinary Pelvic Floor ClinicSarah B Jochum, Hanna Legator, Rana R Abraham, et al.
Plos Pathogens|June 18, 2021
The kinesin of the flagellum attachment zone in Leishmania is required for cell morphogenesis, cell division and virulence in the mammalian hostRosa Milagros Corrales, Slavica Vaselek, Rachel Neish, et al.
Diabetes Research and Clinical Practice|October 1, 1994
Diabetes and diabetes risk factors in second- and third-generation Japanese Americans in Seattle, WashingtonW Y Fujimoto, R W Bergstrom, E J Boyko, et al.
Experimental Eye Research|November 18, 2005
The pharmacokinetics of rituximab following an intravitreal injectionHyuncheol Kim, Karl G Csaky, Chi-Chao Chan, et al.
The British Journal of Dermatology|July 18, 2017
Establishing and prioritizing research questions for the prevention, diagnosis and treatment of hair loss (excluding alopecia areata): the Hair Loss Priority Setting PartnershipA Macbeth, J Tomlinson, A Messenger, et al.
JAMA|October 11, 2007
Efficacy of maintenance treatment approaches for childhood overweight: a randomized controlled trialDenise E Wilfley, Richard I Stein, Brian E Saelens, et al.
Cell Genomics|June 9, 2026
Separating direct, indirect, and parent-of-origin genetic effects in the human populationIlse Krätschmer, Laura Hegemann, Robin J Hofmeister, et al.
Journal of the National Cancer Institute|September 4, 2003
A double-blind, placebo-controlled, randomized trial of oral sodium clodronate for metastatic prostate cancer (MRC PR05 Trial)David P Dearnaley, Matthew R Sydes, Malcolm D Mason, et al.
Pageof 222